Ice3 trial. The ICE3 Trial is a study aimed to evaluate safety and efficacy of cryoab...
Ice3 trial. The ICE3 Trial is a study aimed to evaluate safety and efficacy of cryoablation in low-risk early-stage breast cancer in women ≥60 years. Feb 15, 2022 · Abstract. . ICE3 Trial enrolled patients from 2014 through February 2019. Cryoablation uses extreme cold to destroy tumors by freezing. The trial began in 2014 and has completed recruitment of 206 patients in 19 hospitals and medical centers across the US, including Columbia University Medical Center and Mount Sep 24, 2024 · ICE3 is a non-randomized trial that was conducted at 19 sites in the U. Sep 16, 2024 · Background The ICE3 trial evaluated the safety and efficacy of cryoablation in women aged ≥60 years with low-risk, early-stage breast cancers, aiming to provide a non-operative treatment option and avoid potential surgical risks. Objectives. Apr 30, 2025 · To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer . Methods The ICE3 trial is an Institutional Review Board-approved, prospective, multicentered, non-randomized BACKGROUND: The ICE3 trial evaluated the safety and efficacy of cryoablation in women aged ≥60 years with low-risk, early-stage breast cancers, aiming to provide a non-operative treatment option and avoid potential surgical risks. jsitcwencngxvkqdqsmtvkdnoksdculepikxyrekpkuajiyxvvpal